VCEL

36.81

0.88% 0.32

Pre-mercato: 36.88 0.07 +0.19%

Vericel Corp (VCEL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$36.49

Aprire:

$36.58

Volume 24 ore:

482.36K

Relative Volume:

0.82

Capitalizzazione di mercato:

$1.87B

Reddito:

$276.26M

Utile/perdita netta:

$16.52M

Rapporto P/E:

119.59

EPS:

0.3078

Flusso di cassa netto:

$24.75M

1 W Prestazione:

+3.25%

1M Prestazione:

+7.82%

6M Prestazione:

-1.05%

1 anno Prestazione:

-6.24%

Intervallo 1D:

$35.95

$37.17

Intervallo di 1 settimana:

$33.10

$37.17

Portata 52W:

$28.95

$45.97

Vericel Corp Stock (VCEL) Company Profile

Nome

Vericel Corp

Settore

Healthcare (1106)

Industria

Biotechnology (615)

Telefono

(734) 930-5555

Indirizzo

64 SIDNEY ST., CAMBRIDGE, MA

Dipendente

398

Cinguettio

@VericelCorp

Prossima data di guadagno

2026-05-07

Ultimi documenti SEC

VCEL's Discussions on Twitter

Compare VCEL vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VCEL Vericel Corp	36.81	1.87B	276.26M	16.52M	24.75M	0.3078
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Vericel Corp Stock (VCEL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-17	Downgrade	BTIG Research	Buy → Neutral
2024-08-09	Iniziato	Canaccord Genuity	Buy
2024-06-20	Iniziato	TD Cowen	Buy
2024-01-25	Aggiornamento	Truist	Hold → Buy
2023-08-08	Aggiornamento	BTIG Research	Neutral → Buy
2022-11-10	Downgrade	BTIG Research	Buy → Neutral
2022-11-09	Downgrade	Truist	Buy → Hold
2022-10-14	Ripresa	Stephens	Overweight
2021-01-11	Downgrade	Oppenheimer	Outperform → Perform
2020-12-18	Iniziato	Stephens	Overweight
2020-09-17	Iniziato	Truist	Buy
2019-10-09	Iniziato	H.C. Wainwright	Buy
2019-02-28	Downgrade	Needham	Buy → Hold
2018-08-08	Reiterato	Needham	Buy
2018-07-16	Aggiornamento	Ladenburg Thalmann	Neutral → Buy
2018-04-04	Iniziato	Leerink Partners	Outperform
2018-03-06	Downgrade	Ladenburg Thalmann	Buy → Neutral
2018-03-06	Reiterato	Needham	Buy
2018-03-05	Reiterato	BTIG Research	Buy
2017-06-21	Iniziato	BTIG Research	Buy
2017-03-13	Reiterato	Needham	Buy
2016-12-22	Iniziato	Piper Jaffray	Overweight
2016-11-09	Reiterato	Needham	Buy
2016-04-05	Downgrade	BofA/Merrill	Buy → Neutral
2016-03-11	Aggiornamento	Needham	Hold → Buy

Mostra tutto

Vericel Corp Borsa (VCEL) Ultime notizie

May 05, 2026

Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight - GlobeNewswire Inc.

May 05, 2026

MSN Money - MSN

May 05, 2026

Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity - ChartMill

May 05, 2026

May 04, 2026

Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet - Yahoo Finance

May 04, 2026

May 01, 2026

Vericel (VCEL) director receives new RSU and stock option grants - Stock Titan

May 01, 2026

Vericel (NASDAQ: VCEL) director awarded RSUs and 8,000 stock options - Stock Titan

May 01, 2026

Vericel (NASDAQ: VCEL) director logs RSU conversion and new 8,000-share option grant - Stock Titan

May 01, 2026

Vericel (VCEL) director defers RSUs and receives new option grant - Stock Titan

May 01, 2026

Vericel (VCEL) director reports RSU vesting and new stock option awards - Stock Titan

May 01, 2026

Vericel (VCEL) investors back board slate, executive pay and PwC as auditor - Stock Titan

May 01, 2026

Conestoga Capital Advisors LLC Acquires 79,278 Shares of Vericel Corporation $VCEL - MarketBeat

May 01, 2026

Vericel Annual Meeting: Shareholders Elect Seven Directors, Approve Say-on-Pay and PwC Auditor - Yahoo Finance

May 01, 2026

Apr 30, 2026

Vanguard buys/holds 2.60M Vericel shares — Vericel (NASDAQ: VCEL) - Stock Titan

Apr 30, 2026

Vericel (VCEL) Expected to Announce Earnings on Thursday - MarketBeat

Apr 30, 2026

Apr 28, 2026

Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 28, 2026

Apr 23, 2026

Vericel sets May 7 earnings call, with webcast replay through 2027 - Stock Titan

Apr 23, 2026

Apr 21, 2026

Vericel (NASDAQ:VCEL) Shares Down 7.1%Time to Sell? - MarketBeat

Apr 21, 2026

Apr 17, 2026

VCEL Forecast, Price Target & Analyst Ratings | VERICEL CORP (NASDAQ:VCEL) - ChartMill

Apr 17, 2026

Apr 16, 2026

VCEL Maintains Buy Rating -- Price Target Lowered to $42 by Trui - GuruFocus

Apr 16, 2026

Apr 15, 2026

Truist Cuts Price Target on Vericel to $42 From $48, Keeps Buy Rating - marketscreener.com

Apr 15, 2026

Vericel Corporation (VCEL) secures FDA approval for commercial manufacturing of MACI - MSN

Apr 15, 2026

Apr 14, 2026

Vericel Corporation (VCEL) Stock Price, News, Quote & History - Yahoo Finance

Apr 14, 2026

Critical Limb Ischemia Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Baxter, Ixaka, Hemostemix Inc., Caladrius Biosciences, Vericel Corporation, Helixmith, Lifecells, LLC - Barchart

Apr 14, 2026

Apr 11, 2026

Assessing Vericel (VCEL) Valuation After BARDA Awards Up To US$197 Million NexoBrid Contract - simplywall.st

Apr 11, 2026

Apr 10, 2026

Q3 2025 Vericel Corp Earnings Call Transcript - GuruFocus

Apr 10, 2026

Apr 09, 2026

Is Vericel Corporation (VCEL) Stock Trending Up | Price at $33.41, Down 1.82%Community Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 09, 2026

Apr 08, 2026

Winners Losers: What are the future prospects of Vericel Corporation2026 Major Catalysts & Smart Swing Trading Techniques - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Weekly Trades: Is Vericel Corporation part of any ETF2026 News Drivers & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Jonathan Mark Hopper Sells 3,472 Shares of Vericel (NASDAQ:VCEL) Stock - MarketBeat

Apr 06, 2026

Vericel (VCEL) CMO sells 3,472 shares after option exercise under 10b5-1 plan - Stock Titan

Apr 06, 2026

Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines - Cantech Letter

Apr 06, 2026

After islet transplants, 10 diabetes patients stopped using insulin - Stock Titan

Apr 06, 2026

Aberdeen Group plc Has $21.03 Million Stock Position in Vericel Corporation $VCEL - MarketBeat

Apr 06, 2026

Analysts Set Vericel Corporation (NASDAQ:VCEL) Price Target at $56.00 - Defense World

Apr 06, 2026

Apr 04, 2026

Vericel Corporation (VCEL) Stock forecasts - Yahoo Finance UK

Apr 04, 2026

VCEL SEC FilingsVericel 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 04, 2026

Allspring Global Investments Holdings LLC Cuts Position in Vericel Corporation $VCEL - marketbeat.com

Apr 04, 2026

Apr 03, 2026

Vericel Corporation (VCEL) Stock Forecasts - Yahoo Finance

Apr 03, 2026

Vericel Corporation (NASDAQ:VCEL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Apr 03, 2026

VCEL Stock Analysis: Vericel Corporation 4.85% gain, 34.14 performance outlook - Newser

Apr 03, 2026

Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com India

Apr 03, 2026

Apr 02, 2026

Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com

Apr 02, 2026

Vericel (VCEL) Secures Lucrative Contract with Health and Human Services - GuruFocus

Apr 02, 2026

U.S. stockpile plans include NexoBrid under BARDA deal worth up to $197M - Stock Titan

Apr 02, 2026

MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative

Apr 02, 2026